Abstract This study aimed to determine the causes of sudden cardiac arrest (SCA) in apparently healthy children at a single center in the era of primary prevention (screening questionnaire [SQ]) and secondary prevention (automated external defibrillator [AED] and the automated implantable cardioverter defibrillator [AICD]). Any child 0 to 18 years of age without prior known disease, except for attention deficit disorder, who underwent out-of-the hospital cardiopulmonary resuscitation was included in the study as a SCA subject. A retrospective chart review was used to evaluate the efficacy of the SQ, electrocardiogram (ECG), chest roentgenogram (CXR), and echocardiogram. The findings showed that for 44 of 6,656 children admitted to intensive care with SCA, an AED was used for 39 %, an AICD was placed in 18 %,and survival to hospital discharge was 50 %. The etiology for SCA was identified in 57 % of the cases, mostly in those older than 1 year, and the majority of these had a cardiac etiology (50 %), whereas 7 % had rupture of an arteriovenous malformation. Stimulant medication use was seen in 11 % of the SCA subjects. In the best-case scenario of hypothesized primary prevention, a prior SQ, CXR, ECG, or echocardiogram may have detected respectively 18, 9, 23 and 16 % of the at-risk cases, and 32 % of the cases may have been detected with ECG and SQ together. Based on a historical control cohort, a positive ECG was significantly higher in the children with SCA (p = 0.014). An ECG together with a screening SQ may be more effective in identifying children potentially at risk for SCA than an SQ alone.
Sudden unexplained cardiac arrest (SCA) or death is a rare occurrence in the young, with an incidence of 1.3 to 8.5 per 100,000 patient-years [12, 21] . Although SCA is rare, such a catastrophe is always unexpected for a previously healthy child. Furthermore, these events not only have a devastating impact on the families but also have a tendency to attract considerable public and media attention. This has led to an increase in screening tools and referrals to cardiologists for sports clearance by schools and for clearance to use stimulant medications.
The last decade has seen an increased focus on primary preventive strategies [3] such as a screening Questionnaire [4, 10] with the use of disqualification criteria for participation in physical education and sports, electrocardiography (ECG), and other investigations, as well as secondary preventive strategies [3] such as use of an automated external defibrillator (AED) [11] or an automated implantable cardioverter defibrillator (AICD) [28] . Although a screening Questionnaire currently is used for primary prevention of SCA, the use of additional testing such as a screening ECG is a matter of controversy.
To answer some of these questions and to learn from the children who had undergone such a tragic event in our region, we evaluated their medication history, warning symptoms [13] , family history [13] , diagnostic studies, probable etiology, survival, and modes of secondary prevention. We attempted to evaluate the efficacy of a screening Questionnaire [10] . We also evaluated the benefit of additional studies such as ECG, chest roentgenogram (CXR), and pediatric transthoracic echocardiogram in assessing children for SCA.
Study Design and Methods
The study using a retrospective chart review was approved by the institution's Committee for Protection of Human Subjects. The patients were admitted with an out-of-hospital SCA diagnosis to the Children's Memorial Hermann Hospital and University of Texas at the Texas Medical Center at Houston, the only level 1 pediatric trauma center in the region with Life Flight services providing rapid transport of children with high-acuity events.
The inclusion criteria specified any previously healthy children 0 to 18 years of age with SCA admitted after cardiopulmonary resuscitation to the pediatric intensive care unit (ICU) in the preceding 10 years. The SCA definition included children with sudden death of unknown cause (International Classification of Diseases, 9th edition [ICD-9] code 798). The definition also included children with sudden infant death syndrome (SIDS), instantaneous death, sudden unexplained death (SUD), and sudden cardiac death (SCD) (ICD-9 code 427.5). We included children with attention deficit disorders (ADHD) because they often are treated with stimulant medications.
The exclusion criteria ruled out patients with known medical conditions such as congenital heart disease, cardiac disease including arrhythmias, respiratory disease including asthma, genetic syndromes or diseases, renal diseases, seizures or other neurologic conditions, malignancies or history of malignancies, metabolic diseases, or chronic infectious diseases; traumatic death other than commotio cordis but including shaken baby syndrome and neglect; homicidal, suicidal, or accidental death including drug overdose and drowning; prematurity below 37 weeks of gestation; dehydration; chronic use of medications other than those for ADHD; and a positive urine drug screen for substance abuse.
Besides the consulting cardiologists, two pediatric cardiologists reviewed all cases independently, and any disagreements were resolved by consensus. The children were determined to be receiving a stimulant if they were taking any stimulant medication for ADHD or pseudoephedrine for an upper respiratory tract infection before the cardiac arrest.
Data were obtained by chart review and included demographics, medications, prodromal symptoms, personal and family history, modes of resuscitation and secondary prevention, types of consultations, and the results from diagnostic studies including CXR, echocardiogram, ECG, electrophysiology study, magnetic resonance imaging (MRI), cardiac catheterization, cardiac tomography scan, and others when available, which were used to identify the etiology of the sudden event.
We used a pre-participation Questionnaire [10] , which included the history of certain symptoms, some medical history, and the family history of certain diseases to identify children potentially at risk for SCA. The patient history was used to complete the screening Questionnaire for each patient. The children who did not have a pertinent history for the Questionnaire were not included in the analysis. We estimated the incidence of a positive pre-event ECG, CXR, or echocardiogram based on the findings from the studies conducted after the event.
Statistical Analysis
Descriptive analysis of the data was performed, and the results were expressed as mean ± standard deviation and median (range) for normal data and non-normal distributed continuous data, respectively. Questionnaire data [10] were used to identify individuals who could potentially have been categorized as at risk for SCA had a pre-event screening been performed.
To evaluate whether the proportion of individuals thus identified in the SCD cohort differed from the proportion of positive imaging studies in the pediatric population, the frequencies of these potentially at-risk children were compared with previously reported frequencies in published data [29] . Statistical significance was assumed at a two-sided type 1 error probability of 0.05.
Results
This study included a large multi-ethnic patient population of 6,656 children admitted to a tertiary care intensive care unit from January 2000 to December 2009. The study enrolled 44 patients with SCA (Table 1) , thus showing a 0.7 % prevalence of admissions to the pediatric ICU.
In our study, the inpatient survival to hospital discharge rate was 50 % among the SCA patients, and the survival rate was higher among children 1 to 18 years age group than among infants. An etiology was less evident in infants than in older children.
Cardiac Causes of Sudden Unexplained Cardiac Arrest
Probable causes of SCA were found for about 57 % of patients overall, although a cause was rarely identified for infants ( Table 1 ). The majority of these had a cardiac etiology (50 %). Thus, an etiology for 43 % of the SCAs was not determined. Primary arrhythmias shown by postevent electrophysiology testing were documented for four children including junctional ectopic tachycardia, right ventricular outflow tract tachycardia, left ventricular outflow tract tachycardia, and catecholaminergic polymorphic ventricular tachycardia.
Primary long QT syndrome (LQTS) was diagnosed for two children (1 with positive genetic test results), and secondary LQTS was noted in three children. The determination of primary and secondary long QT syndrome was made by an electrophysiologist, and several ECGs were used to document the disease after correction of all the electrolytes and recovery from the event.
Wolff-Parkinson-White syndrome (WPW) was determined for 6 patients (4 underwent ablation of the accessory pathways; 1 was transferred to a different facility at parental request; and 1 died). One of the children ablated for WPW had a retrograde pathway together with an anomalous right coronary artery anatomy from the left sinus.
Arteriovenous Malformations Associated With Sudden Unexplained Deaths
An arteriovenous malformation (AVM) rupture in the brain, a rare etiology for SCA, also was noted in our study population (Table 2 ). For one patient who died before confirmatory diagnosis, the autopsy report documented rupture of AVM as a high possibility for the cause of death. A positive family history was noted for one patient, whose father died suddenly at the age of 44 years of a ruptured abdominal aneurysm, as shown on his autopsy report. For another child with AVM (not included in this study because he presented with seizures but no SCA), the computed tomography (CT) scan showed intracerebral hemorrhage. The AVM rupture was confirmed with magnetic resonance angiograms and vascular angiograms. This child also had a positive family history of AVMs (paternal grandfather and 2 paternal aunts, all deceased). Thus, 50 % of the children with AVM had a positive family history of AVMs. Coil embolization of AVMs was performed for those who survived the SCA.
Other Possible Risk Factors for Sudden Unexplained Cardiac Arrest
Antecedent use of stimulant medications was noted in five children (11 %) ( Table 3) although their cause and effect with respect to SCA were unknown. Antecedent psychotropic medication use was documented for two of the three children with secondary LQTS and included clonidine, lithium, escitalopram, citalopram, and sertraline. All these medications except clonidine are associated with secondary LQTS. No antecedent ECG was available for these three children. We found a significantly greater number of infants than older children dying during sleep, with 40 % of the older children dying while exercising. We noted antecedent upper respiratory infection in nine of the children (20 %). We evaluated seasonal distribution of the SCA and found no relationship to different seasons in our area.
Hypothesized Primary Prevention of Sudden Cardiac Arrest in Children
A detailed history for the Questionnaire [10] , such as symptoms and family history, was available for 33 (75 %) of the patients. Based on the data entered into the Questionnaire, 18 % of the children had information that would potentially have labeled them as at risk for SCA before the event. For example, the older children had documented antecedent symptoms (palpitations and syncope), and these were marked as positive in the Questionnaire. All the patients had CXR data available, and ECG data were available for 25 (57 %) of the patients. Echocardiographic data were available for 27 (61 %) of the patients. In the best-case scenario, a prior Questionnaire, CXR, ECG, and thorough pediatric transthoracic echocardiogram may have detected respectively 18, 9, 23, and 16 % of the at-risk cases (Table 4) . A pre-event Questionnaire and ECG combined may have detected 32 % of the at-risk children. We compared these findings with those for a historical cohort [29] in a previously published study of 60 consecutive children who had been evaluated by a pediatric cardiologist for cardiac symptoms or signs and found to have no heart disease at physical examination. Subsequent imaging studies of these children identified 1 CXR (2 %), 3
ECGs (5 %), and 12 echocardiograms (7 %) that were positive for any heart disease [29] . Based on a historical control cohort [29] , a positive ECG was significantly higher in children with SCA (p = 0.014) ( Table 4) .
Discussion
Cardiac disease remains the primary cause of SCA in apparently healthy children [5, 15] , as confirmed by our study. It can be due to several causes including coronary artery anomalies [30] , infectious [1] and noninfectious cardiomyopathies, and arrhythmogenic substrates [5] .
In this era of advanced imaging, autopsies [31] alone may not provide an insight into the cause of SCA because many of the arrhythmogenic substrates account for one third of autopsy-negative sudden unexplained deaths in children. However, the addition of genetic testing [6] and metabolic evaluation can improve the yield of an autopsy. Although cardiac disease makes up a significant portion of the etiology for SCA, as reported in the literature, a ruptured AVM also has been identified as a possible cause of SCA [22] . With improving imaging capabilities, an AVM is perhaps diagnosed more often, accounting for 7 % of the SCA in our study. Regarding secondary prevention, we found that an AED was used for 39 % patients during resuscitation, and 18 % received an AICD for malignant arrhythmias or cardiomyopathies. The inpatient survival to hospital discharge at our center was 50 % for SCA.
The children younger than 1 year had a significantly higher incidence of SCA or SIDS during sleep, a lower detection of an etiology for SCA, and a lower survival rate than the older children in our study. Compared with the younger children, about 40 % of the older children in our cohort had an event while exercising. These findings are consistent with earlier reports of SCA observed among competitive athletes [9] and SIDS observed during sleep [16] .
We noted antecedent upper respiratory infection in nine (20 %) of the children in our cohort. We included upper respiratory tract infection as a possible associated risk factor for SCA because of the following reasons. First, this infection is associated with use of over-the-counter medications, which may contain stimulants such as pseudoephedrine. Second, it may be associated with a subclinical myocarditis. Furthermore, upper respiratory tract infections have been associated with SCA in infants [23, 32] and older children.
Winter months have been associated with SIDS, although one study did not find any seasonal variation [32] . Many conditions can cause seasonal variation in SCA among children including discontinuation of physical education and decreased use of stimulant medications for ADHD during summer breaks, higher incidence of viral infections, swaddling during winter months, and so on. We did not find any seasonal predilection for SCA in our study.
Our study found that 11 % of the SCAs had stimulant use before the event, including stimulants such as pseudoephedrine and medications for ADHD. We included pseudoephedrine under stimulants because it is a sympathomimetic amine similar to ephedrine and also has been associated with SCA in children [23] . We found that 7 % of the SCA episodes were related to stimulants used for ADHD, and although cause and effect were not established between the two, 100 % of these patients had an additional cardiac abnormality.
Children with ADHD who died suddenly had congenital junctional ectopic tachycardia, hypertrophic cardiomyopathy, and secondary long QT syndrome most likely related to additional psychotropic medications. These three diseases could most likely have been diagnosed by a pre-event ECG. The stimulant medication, used for 2 % to 18 % of the children in the general population [25] , has central and peripheral catecholaminergic effects and has been documented in the literature as a possible contributor of acute mortality in children [3, 8, 17, 19, 23] . However, one very large study has shown an elevated but statistically nonsignificant hazard ratio of SCA [27] . Stimulant use and abuse can lead to a statistically significant increase in heart rate [18, 26] , blood pressure [18, 26] , and cardiomyopathies, all increasing the risk for arrhythmias and sudden cardiac arrest [17] .
Stimulants also have the potential of abuse among children. Especially performance-enhancing drugs among athletes [7] and hence SCA due to the use of stimulants are perhaps underdiagnosed and underreported. The Food and Drug Administration (FDA) review of patients taking stimulant medications for the treatment of ADHD followed the report documenting 25 cases of sudden cardiac death among patients treated with methylphenidate (7 children and 1 adult), and amphetamine (12 children and 5 adults) and the cases of 54 additional people who had serious cardiovascular events during the period 1999-2003.
An FDA review of the cardiovascular risks associated with the use of stimulants in children and adults did not find increased risk except for those with underlying heart disease. For them, a black box warning was included on pharmaceutical package inserts. These findings by the FDA were confirmed by our study.
We found that based on a historical cohort of apparently healthy children without SCA, the prevalence of an abnormal ECG was significantly higher among those with SCA. Also, findings from our study suggest that all three children (100 %) receiving stimulants for ADHD may have benefited from obtaining an ECG before starting the medications.
A recent metaanalysis has shown that an ECG has high sensitivity for mass screening of asymptomatic children with detectable causes of SCA such as hypertrophic cardiomyopathy, LQTS, and WPW [24] . The current recommendations by the American Academy of Pediatrics [2, 3, 35] , FDA's Pediatric Advisory Committee [20] , and the American Academy of Child and Adolescent Psychiatry [14] do not include an ECG for screening of a child before stimulants are started for ADHD or participation in sports.
The American Heart Association recommends that obtaining an ECG before stimulants are started is a reasonable option and further recommends a cardiology consultation if the history, physical examination, or ECG raises any red flags [33] . Although it is an important first step, a screening questionnaire alone is not sufficient to separate the low-risk children from the high-risk children. Based on our findings, an ECG together with the screening Questionnaire [10] would improve detection of at-risk children compared with the Questionnaire [10] alone. We recommend confirming these findings with a large prospectively conducted study. We further recommend adding a history of the following known risk factors to the screening Questionnaires: use of all medications including nonprescription drugs and supplements, Kawasaki disease [34] , attention deficit disorder, psychiatric disorder, and family history of aneurysms and AVMs. Currently recommended screening Questionnaires [10, 3] are incomplete in some of these important data.
Limitations of the Study
This retrospective study involved a review of medical records and hence had many of the limitations inherent to such a study, including reporting bias. We did not have access to information regarding the history of exposure to nicotine, either as substance abuse or as a second-hand exposure. For deaths among infants, we had no data on maternal age or fetal exposure to substance use. We could not confirm the sleep position of the children who died during sleep. Details on stimulant medications regarding duration of use before cardiac arrest and so forth were unknown. Genetic, metabolic, and toxicology tests (besides the urine drug screen) also were lacking for all the patients.
We excluded children who died at the scene or were dead on arrival at the emergency department. Hence, the data are limited to children resuscitated initially and admitted to the pediatric ICU. The study included children from a large metropolitan area, so the results may not be generalizable to other demographic locations.
We may have overestimated the incidence of a positive pre-event ECG, CXR, or echocardiogram based on the findings of the studies after the event. For example, a distinctive finding of WPW syndrome can be intermittently absent on ECGs for the same child, but we considered it to be positive if we found a positive ECG after the event.
Similarly, a CXR can easily miss early cardiomyopathy or myocarditis. However, if the CXR was positive after the event, we then considered it as positive for a pre-event diagnosis. Finally, we did not have a randomized control group for the Questionnaire or imaging studies. Hence, the study lacked sensitivity analysis.
Conclusions
The etiology of SCA in apparently healthy children appears to be predominantly cardiac in origin. A screening Questionnaire together with an ECG appears to be a more effective strategy for detecting children at risk for sudden unexplained cardiac arrest than a screening Questionnaire alone.
